Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety Study of FSME-IMMUN NEW in Healthy Children and Adolescents Aged 1 to 15 Years
This study has been completed.
Study NCT00161863   Information provided by Baxter Healthcare Corporation

First Received on September 8, 2005.   Last Updated on October 18, 2006   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Tick-Borne Encephalitis
Additional conditions recognized in this trial
Encephalitis
Encephalitis, Tick-Borne
More general conditions related to this trial
Arbovirus Infections
Brain Diseases
Central Nervous System Diseases
Central Nervous System Infections
Central Nervous System Viral Diseases
Encephalitis, Arbovirus
Encephalitis, Viral
Flaviviridae Infections
Flavivirus Infections
Nervous System Diseases
RNA Virus Infections
Tick-Borne Diseases
Virus Diseases
Interventions listed in this trial
FSME-IMMUN NEW 0.25 ml
Sponsors listed in this trial
Baxter Healthcare Corporation


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services